{Reference Type}: Journal Article
{Title}: Diversity in pulmonary rehabilitation clinical trials: a systematic review of the literature.
{Author}: Chopra S;Rana S;Patel R;Hamilton T;Dalip A;Malhi P;Camp PG;
{Journal}: Expert Rev Respir Med
{Volume}: 18
{Issue}: 1
{Year}: 2024 Jan-Feb 6
{Factor}: 4.3
{DOI}: 10.1080/17476348.2024.2324086
{Abstract}: <B>UNASSIGNED: </B>Underrepresentation of minority groups in clinical trials may hinder the potential benefits of pulmonary rehabilitation (PR) programs for individuals with chronic obstructive pulmonary disease (COPD). The aim of this work was to determine whether participants in PR randomized control trials (RCTs) conducted in the U.S.A., Canada, the UK, and Australia are representative of ethnicity, sex, gender, and sociodemographic characteristics.<BR><B>UNASSIGNED: </B>A systematic search was performed for relevant literature from inception to December 2022. Titles and abstracts were screened before undergoing a full article review. Relevant data on reporting of age, sex, gender, ethnicity, and sociodemographic characteristics of participants was extracted.<BR><B>UNASSIGNED: </B>Thirty-six RCTs met the inclusion criteria. Only 6% of publications reported on ethnicity, with ≥90% of participants reported as 'White.' All 36 papers reported on age, with the mean between 60 and 69 years old. Thirty-five studies reported on sex (97%), with the majority (67%) reporting more male than female participants. There was no mention of different genders in any paper. Other sociodemographic factors were reported in 7 (19%) papers.<BR><B>UNASSIGNED: </B>Inclusivity and representation in clinical trials are essential to ensure that research findings are generalizable. Clinical trialists need to consider the demographics of today's society during recruitment.